+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Screening and management of renal disease in human immunodeficiency virus-infected patients in Australia

Screening and management of renal disease in human immunodeficiency virus-infected patients in Australia

Internal Medicine Journal 43(4): 410-416

Renal disease has become one of the most important comorbidities observed in the human immunodeficiency virus (HIV)-infected patient cohort. Data are lacking on the current screening and management of renal disease in patients with HIV. We evaluated HIV-infected Australian adults in primary care to determine current practices. This prospective, multicentre observational study included two rounds of data collection; the first was followed by an educational programme. Outcomes included screening for renal disease; management of risk factors for kidney disease and other comorbidities associated with renal disease. Fifty-three general practitioners participated with 733 patients enrolled. Most were male (94%); almost 40% were 41-50 years of age, and 6% and 84% were receiving antiretroviral therapy. Comorbidities were common; 19% had hypertension, 5% were diabetic, 32% were dyslipidaemic, and 40% were smokers. Estimated glomerular filtration rate was commonly measured in both rounds of data collection (96% vs 95%). Proteinuria was assessed less frequently; this improved after education (48% vs 71%). Almost 10% of patients tested had proteinuria on urinalysis. Of the 45 patients (6%) with renal impairment (estimated glomerular filtration rate <60 mL/min), none was referred for assessment by a renal specialist. This large observational study provides important information on renal disease in HIV-infected patients, an area with a paucity of clinical data. Current screening and management practices fall short of suggested guidelines. Failure to refer patients to specialists is a major deficiency. Improvements with education suggest the need to promote awareness of guidelines in primary care doctors.

(PDF emailed within 0-6 h: $19.90)

Accession: 055670273

Download citation: RISBibTeXText

PMID: 22931386

DOI: 10.1111/j.1445-5994.2012.02933.x

Related references

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients. Enfermedades Infecciosas Y Microbiologia Clinica 32(9): 583-597, 2014

Importance of screening for renal disease among the human immunodeficiency virus-infected patient population. Internal Medicine Journal 42(8): 954-955, 2013

Prevalence of viremia in human immunodeficiency virus-infected patients with renal disease. Archives of Internal Medicine 155(15): 1578-1584, 1995

Spectrum of Clinical Presentations in Human Immunodeficiency Virus (HIV) Infected Patients with Renal Disease. African Journal of Infectious Diseases 5(2): 28-32, 2011

End-stage renal disease in patients infected with human immunodeficiency virus: a retrospective review of 38 cases. Journal of the National Medical Association 87(10): 762-765, 1995

Impaired maraviroc and raltegravir clearance in a human immunodeficiency virus-infected patient with end-stage liver disease and renal impairment: a management dilemma. PharmacoTherapy 32(1): E1-E6, 2012

The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis. American Journal of Kidney Diseases 25(6): 904-909, 1995

Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S. transplant centers. Transplantation 65(9): 1187-1191, 1998

Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients. World Journal of Nephrology 4(3): 388-395, 2015

Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer 92(11): 2739-2745, December 1, 2001

Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis. Antimicrobial Agents and ChemoTherapy 46(8): 2387-2392, 2002

Clinical characteristics and renal biopsy findings in human immunodeficiency virus infected outpatients with renal disease. Journal of the American Society of Nephrology 7(9): 1342, 1996

Quality of life among human immunodeficiency virus-1 infected and human immunodeficiency virus-1/hepatitis C virus co-infected individuals in Iranian patients. Nigerian Medical Journal 57(1): 49-53, 2016

Renal disease in human immunodeficiency virus hiv infected children. Kidney International 35(1): 368, 1989